| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/03/2007 | CN1887294A Orally taken liquid medicine composition containing strontium |
| 01/03/2007 | CN1293098C Concatameric immunoadhesion |
| 01/03/2007 | CN1293090C 9-alpha-substituted estratrienes as selectively active estrogens |
| 01/03/2007 | CN1293076C Activator for peroxisome proliferator-activated receptor delta |
| 01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
| 01/03/2007 | CN1293064C Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1292768C Externally used pharmaceutical for bone fracture |
| 01/03/2007 | CN1292767C Compound sichuan lovage rhizome tincture and its preparation process |
| 01/03/2007 | CN1292765C Pharmaceutical composition for treating rheumatoid and rheumatic arthritis, its preparation process and usage |
| 01/02/2007 | US7157604 Selective estrogen receptor modulators |
| 01/02/2007 | US7157498 Diamines having a CaSR modulating activity |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157450 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157080 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 01/02/2007 | CA2400226C Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 01/02/2007 | CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 01/02/2007 | CA2197869C Therapeutic agent for cartilaginous diseases |
| 12/28/2006 | WO2006138690A2 Improved method of treating degenerative spinal disorders |
| 12/28/2006 | WO2006138038A1 Intralesional treatment of psoriasis |
| 12/28/2006 | WO2006137509A1 Cyclic amine derivative containing ppar regulator |
| 12/28/2006 | WO2006137469A1 Metabotropic glutamate receptor activator |
| 12/28/2006 | WO2006137450A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 12/28/2006 | WO2006111720A3 Use |
| 12/28/2006 | WO2006099480A3 Stress proteins and peptides and methods of use thereof |
| 12/28/2006 | WO2006081251A3 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 12/28/2006 | WO2006012492A8 Compositions and methods for viscosupplementation |
| 12/28/2006 | WO2005045025A3 Cloning and characterization of 5’ flanking regions of a human aggrecanase-1 gene |
| 12/28/2006 | WO2003072714A3 Follistatin domain containing proteins |
| 12/28/2006 | US20060293391 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 12/28/2006 | US20060293375 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293335 Riboflavin derivative and its manufacture and uses |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293297 Cyanofluoropyrrolidine derviative |
| 12/28/2006 | US20060293291 bone formation is desired, such as osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus; exhibit pronounced activity in arresting the proliferation of undifferentiated cells; 2-[(3'-methoxymethoxy)propylidene]-19-nor-1 alpha ,25-(OH)2,D3 |
| 12/28/2006 | US20060293275 Hgf production accelerator containing heparin-like oligosaccharide |
| 12/28/2006 | US20060293252 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 12/28/2006 | US20060293221 Mucosal repair by TFF2 peptides |
| 12/28/2006 | US20060293220 Thermodynamically stable calcium phosphate nanoclusters formed from a solution of calcium, phosphate and casein-type peptides; food and beverage additives; used for treatment of pathological calcification and prevention of tooth demineralization |
| 12/28/2006 | US20060292670 Nell peptide expression systems and bone formation activity of nell peptide |
| 12/28/2006 | US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases |
| 12/28/2006 | US20060292644 Novel tumor-associated marker |
| 12/28/2006 | US20060292150 Methods of using wisp antagonists |
| 12/28/2006 | US20060292147 Blood MMP-3 level-lowering agent comprising IL-6 antagonist as active ingredient |
| 12/28/2006 | US20060292133 Use of lactobacillus salivarius |
| 12/28/2006 | US20060292131 Chondrocyte Therapeutic Delivery System |
| 12/28/2006 | CA2678008A1 Methods of treating a secondary bone tumor with anti-pdgfralpha antibodies |
| 12/28/2006 | CA2633030A1 Intralesional treatment of psoriasis |
| 12/28/2006 | CA2613253A1 Combination comprising amino alcohol derivatives as immunosuppressants |
| 12/28/2006 | CA2613249A1 Crystals of phenylalanine derivatives, production method thereof and use thereof |
| 12/28/2006 | CA2606084A1 Improved method of treating degenerative spinal disorders |
| 12/28/2006 | CA2598216A1 Androgen receptor modulator compounds and methods |
| 12/27/2006 | EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof |
| 12/27/2006 | EP1736541A1 Novel galectin 9 modification protein and use thereof |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736173A1 Damaged tissue therapeutic agent and therapeutic method |
| 12/27/2006 | EP1735298A1 Piperidine derivates for the treatment of chemokines mediared disease |
| 12/27/2006 | EP1735277A1 2-alkylidene-18,19-dinor-vitamin d compounds |
| 12/27/2006 | EP1735274A1 Nonpeptide inhibitors of matrix metalloproteinases |
| 12/27/2006 | EP1734985A2 Methods for suppressing neovascularization using ephrinb2 |
| 12/27/2006 | EP1734977A1 Medicament for relief of symptoms of joint disorders and inflammatory conditions |
| 12/27/2006 | EP1734964A1 17 beta-acetamide-4-azasteroids as androgen receptor modulators |
| 12/27/2006 | EP1734952A1 Protein kinase c inhibitors for the treatment of autoimmune diseases and of transplant rejection |
| 12/27/2006 | EP1480961B1 Glutaminyl based dpiv inhibitors |
| 12/27/2006 | EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/27/2006 | EP1392276B1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 12/27/2006 | EP1368317B1 Tryptase inhibitors |
| 12/27/2006 | EP1354047B1 Methods for screening compounds that modulate lipid metabolism |
| 12/27/2006 | EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
| 12/27/2006 | EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/27/2006 | EP1226144B1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 12/27/2006 | EP1073739B1 Cd40-interacting and traf-interacting proteins |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | EP0783891B1 Interferon-beta for bone diseases |
| 12/27/2006 | CN1886423A Glycoisoforms of adiponectin and uses thereof |
| 12/27/2006 | CN1886375A Piperidine compound and method for producing same |
| 12/27/2006 | CN1886157A Pharmaceutical combinations |
| 12/27/2006 | CN1886145A Composition for preventing and treating climacteric symptoms comprising the extract of sophorae fructus |
| 12/27/2006 | CN1884302A Staphylococcus aureus fusion protein of fibronectin and bindin, its preparation method and uses |
| 12/27/2006 | CN1883698A Health product for resisting inflammation, stopping pain and promoting rehabilitation of articular cartilage |
| 12/27/2006 | CN1883693A Chinese medicinal composition for treating scapulohumeral periarthritis |
| 12/27/2006 | CN1883668A Dry concentrate of yellow wine and preparation method thereof |
| 12/27/2006 | CN1883635A Tendon-relaxing blood circulation-activating capsule and preparation process thereof |
| 12/27/2006 | CN1883630A Oral liquid for treating traumatic injury and method for preparing same |
| 12/27/2006 | CN1883628A Externally applied medicine for treating hyperosteogeny |
| 12/27/2006 | CN1883626A Capsule for treating gout and preparation process thereof |
| 12/27/2006 | CN1883618A Effective parts of cirald daphne bark, preparation method and application thereof |
| 12/27/2006 | CN1883591A Chinese medicine for treating scapulohumeral periarthritis |
| 12/27/2006 | CN1883584A Chinese medicine for treating protrusion of lumbar intervertebral discs |